Tesla Q1 deliveries may decline sharply amid weak Europe and China sales. Read more about TSLA stock here and why it is a ...

During Q4, the portfolio posted a negative total return but outperformed its benchmark (the Bloomberg U.S. Aggregate Index).

Gannett is in the middle of turning the business into digital, which could eventually lead to multiple expansion. Read why ...

All told, both short- and long-term Treasury yields rose sharply and the overall US bond market, as measured by the Bloomberg ...

Altria faces challenges in the vape market and valuation pressure, but its 7% dividend yield and tariff insulation offer ...

Neuronetics' strategic acquisitions, including Greenbrook, and FDA approvals are expected to drive revenue growth. See why ...

Global banks shed their holdings in spot crypto assets in the second quarter of last year, instead pivoting toward regulated, ...

U.S. Defense Secretary Pete Hegseth announces plans to reduce the Department of Defense's civilian workforce, reallocating ...

Q1 deliveries are expected to drop by 8.5%, with production hurdles and shrinking market share impacting growth.

Top FDA vaccine official Peter Marks resigns, citing misinformation by HHS Secretary Kennedy. Learn the impact on public ...

Discover how President Trump's executive order on DEI programs impacts French companies with U.S. federal contracts amid ...

NuVista Energy is attractive thanks to sector-leading production growth, a pristine balance sheet, and cheap valuation ...